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We showed previously that eiger, the Drosophila tumor necrosis factor homolog, contributes to the pathology induced
by infection with Salmonella typhimurium. We were curious whether eiger is always detrimental in the context of
infection or if it plays a role in fighting some types of microbes. We challenged wild-type and eiger mutant flies with a
collection of facultative intracellular and extracellular pathogens, including a fungus and Gram-positive and Gram-
negative bacteria. The response of eiger mutants divided these microbes into two groups: eiger mutants are
immunocompromised with respect to extracellular pathogens but show no change or reduced sensitivity to facultative
intracellular pathogens. Hence, eiger helps fight infections but also can cause pathology. We propose that eiger
activates the cellular immune response of the fly to aid clearance of extracellular pathogens. Intracellular pathogens,
which can already defeat professional phagocytes, are unaffected by eiger.
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Introduction
The fruit ﬂy has four main immune mechanisms to ﬁght
circulating microbes. These mechanisms include secreted
antimicrobial peptides (AMPs), melanization, clotting, and
phagocytic hemocytes [14]. The most deeply studied of these
mechanisms, AMP secretion, is controlled by the Toll and imd
pathways, which regulate the transcription of AMP genes in
the fat body. Signaling through the Toll and imd pathways is
activated by microbial elicitors; for example, the receptor
peptidoglycan receptor protein LC, one receptor that
triggers imd signaling, is activated by diaminopimelic acid–
containing peptidoglycan [5,6]. This material is found on
most Gram-negative bacteria as well as some Gram-positive
bacteria.
Mutations affecting the Toll and imd pathways severely
immunocompromise ﬂies. Although Toll and imd mutant ﬂies
get sick and die from infections, this does not resemble many
infectious processes in healthy humans. For example, an imd
mutation essentially turns ﬂies into a passive culture medium
for Escherichia coli; the bacteria grow 1,000-fold in 24 h [7,8].
Immunocompromised infected ﬂies likely die from the
enormous load of bacteria that can reach levels of more than
1% of the mass of the ﬂy. Death from massive numbers of
microorganisms can happen in humans, particularly in
immunocompromised patients; however, the infectious
agents that are responsible for the greatest mortality in
humans—Mycobacterium tuberculosis, HIV, Plasmodium falcipa-
rum, and diarrhea-inducing microbes—do not work in this
manner. Instead, relatively small numbers of these infectious
agents cause various pathologies that lead to death. To study
microbial pathogenesis in the ﬂy, it is necessary to follow
microbes that cause disease in wild-type ﬂies.
Pathogens are different from nonpathogenic bacteria and
simple molecular elicitors of innate immunity, and thus the
results we see from experiments with pathogens will be
different than those observed for simple elicitors like E. coli
and Micrococcus luteus. For one thing, pathogens can override
the strong immune defenses of the ﬂy; this causes disease. In
ﬂies, as in humans, there is more than one type of disease that
results from infection. Pathogens have been observed to kill
the ﬂy in at least four different ways: ﬁrst, overactivation of
the Toll or imd pathways can be pathogenic [9,10]; second,
Vibrio cholera fed to ﬂies kills the ﬂy through the secretion of
toxins that presumably cause physiological changes to the gut
[11]; third, M. marinum causes a wasting disease in ﬂies [12];
and fourth, Salmonella typhimurium secretes effectors through
its type III secretory system that increase the pathogenicity of
the microbe. The ﬂy gene eiger, the ﬂy’s sole tumor necrosis
factor homolog, is implicated in causing pathology during
this infection because S. typhimurium–infected eiger mutant
ﬂies live longer than infected wild-type ﬂies [13]. It appears
that there are many physiological routes that can lead to
death following infection.
We have begun to try to understand these physiological
routes to death by analyzing the role played by eiger in a
variety of infections. The eiger mutation divided our group of
pathogens into two unanticipated groups. The ﬁrst group of
microbes kills eiger mutants more rapidly than wild-type ﬂies;
this group includes a fungus as well as both Gram-positive
and Gram-negative bacterial species. The second group of
microbes kills eiger mutants at the same rate or more slowly
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These results cut across the previous descriptions of
Drosophila immunity, which groups microbes according to
their gross physical characteristics [2,3]. The most obvious
way to explain the grouping of these pathogens in eiger
mutants is not by grouping microbes according to their
Gram-staining properties or kingdom, but rather by their
pathogenesis mechanisms; the ﬁrst group of microbes
consists of extracellular pathogens while the second group
contains microbes that can grow within professional phag-
ocytes. eiger appears to play a role in innate immunity in
ﬁghting extracellular pathogens but plays a role in driving
pathogenesis when ﬁghting some intracellular pathogens.
This study demonstrates that the examination of real
pathogens and the use of outputs other than AMP tran-
scription leads to the discovery of unanticipated immune
pathways and reveals new complexities in the Drosophila
immune system.
Results/Discussion
To determine the role eiger plays in ﬁghting microbial
pathogens, we tested a collection of Gram-positive, Gram-
negative, and fungal pathogens that could cause either
intracellular or extracellular infections (Table 1). Our goal
was to test a broad group of microbes that used different
virulence mechanisms and were recognized by different
innate immunity pathways.
We tested a heterozygous combination of two eiger null
alleles (w
1118; egr
1/egr
3) and compared this to an isogenic w
1118
parental strain (Figure 1). eiger mutants died much faster than
wild-type ﬂies when challenged with Beauveria bassiana,
Burkholderia cepacia, Enterococcus faecalis, Staphylococcus aureus,
and Streptococcus pneumoniae (Figure 1). The members of this
group of microorganisms are very different from each other
and include Gram-positive and Gram-negative bacteria and a
fungus. The smallest effect on survival was a 50% reduction in
the mean time of death for B. bassiana infections. The effect
was strongest with eiger mutants infected with S. aureus and
E. faecalis; whereas the chosen doses were nonpathogenic to
wild-type ﬂies (i.e., they died at the same rate as media-
injected controls), eiger mutants died within 2 d. The one
common characteristic of this group is that these microbes
are all expected to produce extracellular infections.
eiger mutant ﬂies did not die faster when infected with the
three facultative intracellular pathogens we tested (Figure 1).
We reported previously that eiger mutants live longer than
wild-type ﬂies when infected with S. typhimurium. This result
led us to suggest that eiger activity could be deleterious for the
ﬂy and was a cause of pathology. We found that M. marinum–
infected eiger mutants also live longer than infected wild-type
ﬂies. Finally, eiger mutants and wild-type ﬂies survive exactly
t h es a m ea m o u n to ft i m ew h e ni n f e c t e dw i t hListeria
monocytogenes.
We tested E. coli as a nonpathogenic control (Figures 1 and
S1). We deﬁne a pathogen as a microbe that increases the
death rate of infected ﬂies as compared to a control ﬂy
injected with medium. This microbe was chosen because it
played a major role in characterizing the immune response of
the ﬂy. E. coli is normally a good inducer of innate immune
responses when injected into the ﬂy but will only cause
disease in ﬂies missing the imd pathway. E. coli injection does
not kill eiger mutants or wild-type ﬂies. This suggests either
that eiger does not play a role in ﬁghting a nonpathogenic
infection or that eiger’s role is redundant and therefore
undetectable by this assay.
We next decided to determine whether eiger mutant ﬂies
were killed faster by extracellular pathogens because of
increased bacterial growth or increased pathogenesis by
Table 1. Microbial Strain List
Microbe Strain Class Infection Toll Mutant Phenotype imd Mutant Phenotype Reference
B. bassiana 80.2 Fungus Extracellular Sensitive Not sensitive [8]
B. cepacia ATCC25416 Gram-negative Extracellular Not sensitive Sensitive Unpublished data
E. coli DH5a Gram-negative Extracellular Not sensitive Sensitive [7]
E. faecalis V583 Gram-positive Extracellular Sensitive Sensitive [24]
L. monocytogenes 10403S Gram-positive Intracellular Sensitive Sensitive [14]
M. marinum M Mycobacterium Intracellular Not sensitive Not sensitive [25]
S. aureus Clinical isolate Gram-positive Extracellular Sensitive Sensitive [24]
S. pneumoniae SP1 Gram-positive Extracellular Sensitive Sensitive Unpublished data
S. typhimurium SL1344 Gram-negative Intracellular Not sensitive Sensitive [13]
The designation ‘‘sensitive’’ indicates that the indicated mutant fly dies faster than a parental control when infected with the listed microbe; ‘‘not sensitive’’ means that there is no change
with regard to the parental phenotype, but because most of these microbes are pathogens, the flies ultimately die from the infection.
doi:10.1371/journal.ppat.0030041.t001
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Author Summary
We show that the gene eiger, which is the sole tumor necrosis factor
homolog in the fruit fly, can play opposing roles in the fly’s response
to infections. Sometimes eiger contributes to the disease induced by
an infection, while at other times it is required to fight an infection.
Commonly, the fly’s immune response is described as dividing
microbes into two groups with Gram-positive bacteria and fungi
lying in one group and Gram-negative bacteria lying in the other.
Pathogenic bacteria can also be divided into two groups based on
their behavior in eiger mutant flies, but these two groups differ from
past descriptions. eiger tends to be required for the innate immune
response against extracellular pathogens but tends to cause
pathology during an infection with an intracellular pathogen. We
suggest that eiger is required for innate immune responses that are
effective at fighting extracellular pathogens but are wasteful or
simply ineffective when fighting intracellular pathogens. We show
here that the fly immune response is more complex than previously
recognized and suggest new directions for studying pathogenesis in
addition to innate immunity in the fly.monitoring bacterial proliferation in infected ﬂies (Figure 2).
As before, bacteria were injected into age-matched male wild-
type parental or isogenic transheterozygous eiger mutant ﬂies.
Flies were collected and homogenized following bacterial
challenge to measure bacterial loads.
Of the four bacterial species that showed increased
virulence in eiger mutants, two—B. cepacia and S. pneumo-
niae—had statistically signiﬁcant increased growth rates in
eiger mutants. There was no clear effect on E. faecalis growth
rates in eiger versus wild-type ﬂies. S. aureus showed a large
variation in bacterial numbers toward the end of the
infection that suggested a trend toward increased growth;
for example, the highest levels of bacteria found in eiger
mutants were 10,000 higher than those seen in wild-type ﬂies.
However, because the variation was so great in eiger mutants,
the difference between wild-type and eiger mutants was not
statistically signiﬁcant. We suggest that S. aureus might not
cause synchronous infections and thus that some ﬂies
succumb to infection rapidly and have high numbers of
bacteria while others take longer to die and maintain lower
levels of bacteria. This would result in a huge range of
bacterial titers in a group of injected ﬂies. E. coli were cleared
at comparable rates in eiger and wild-type ﬂies. B. bassiana was
not tested because we do not have a good quantitative
method of measuring fungal growth. In summary, these
bacterial growth measurements show that eiger mutants are
unable to limit the growth of two and possibly three of the
four extracellular pathogens tested. This experiment does not
rule out the possibility that eiger mutants suffer greater
pathological effects of infection but does suggest that eiger in
a wild-type ﬂy plays a role in reducing the numbers of
extracellular microbes.
Figure 1. Survival of eiger Infected Flies
Week-old male flies were infected with pathogens and survival was monitored daily. (A) S. typhimurium; (B) M. marinum, (C) L. monocytogenes, (D) E. coli,
(E) S. aureus, (F) E. faecalis, (G) B. bassiana, (H) S. pneumoniae, (I) B. cepacia. Circles indicate medium-injected eiger; diamonds, microbe-injected eiger;
squares, microbe-injected parental; triangles, medium-injected parental. Medium injection is indicated by a dotted line, while microbe injectioni s
indicated by a solid line. Statistical significance was determined using log-rank analysis. The infected eiger and wild-type curves in (A), (B), and (E–I) are
significantly different with p , 0.0001 as determined by log-rank analysis.
doi:10.1371/journal.ppat.0030041.g001
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not increase in eiger mutants. As we published previously,
S. typhimurium levels remained constant in an eiger homozy-
gote as compared to an isogenic wild-type ﬂy [13].
L. monocytogenes numbers decreased signiﬁcantly in eiger
mutants with respect to wild-type ﬂies even though both
wild-type and mutant ﬂies died at the same rate. Our
interpretation is that eiger is somehow helpful for the growth
of Listeria. We did not measure the growth rate of M. marinum.
There is no simple interpretation, using Toll or imd
signaling, that can explain the difference in sensitivity of
eiger mutants to the tested pathogens. If the eiger mutation
resulted in decreased Toll signaling, then we would expect
Listeria to kill the ﬂies rapidly as has been reported [14].
Likewise, a reduction of imd activity would immunocompro-
mise the ﬂies to S. typhimurium. imd mutants are very sensitive
to S. typhimurium and will die within 24 h when infected with
as little as a single colony-forming unit [13]. Furthermore, if
imd signaling was affected, we would expect ﬂies to become
sensitive to E. coli, which they do not [7]. We are forced to
conclude that the strong effects of eiger on the pathogenesis
caused by extracellular microbes are not caused by a
reduction in signaling through the Toll and imd pathways.
To test the hypothesis that Toll and imd signaling are not
grossly reduced by a mutation in eiger, we measured the
induction of AMP transcription in eiger and parent strains
(Figure 3). Flies were challenged with S. typhimurium, B. cepacia,
L. monocytogenes, and S. aureus as well as an LB control, and
these conditions were compared to expression levels seen in
uninfected ﬂies. We chose this subset of bacteria because it
included both Gram-positive and Gram-negative examples of
intracellular and extracellular pathogens. Toll signaling was
monitored by following drosomycin gene induction using
quantitative reverse transcription (RT)-PCR, although we
note that there are no perfect Toll responsive genes and
drosomycin is responsive to both Toll and imd signaling [15]. To
measure the output of the imd pathway, we monitored the
expression of the diptericin gene. No statistically signiﬁcant
changes in drosomycin transcription were seen between
parental and eiger mutant ﬂies. Some conditions caused a
relatively small, but statistically signiﬁcant increase in
diptericin transcription in eiger mutants. We do not understand
Figure 2. Bacterial Growth in eiger Mutants
Week-old male flies were infected with pathogens, and flies were collected at 0, 2, 6, 24, and 48 h, if there were survivors. Live flies were homogenized
and plated: (A) S. typhimurium; (B) L. monocytogenes; (C) E. coli; (D) S. aureus; (E) E. faecalis; (F) S. pneumoniae; (G) B. cepacia. Data are plotted as box plots
with whiskers. White bars indicate the parental w
1118 line; gray bars, w
1118; eiger
1/eiger
3 mutants. Statistical significance was calculated using two-tailed
nonparametric t-tests.
doi:10.1371/journal.ppat.0030041.g002
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eiger mutants might affect the eiger phenotype. The important
point is that eiger mutants did not have lower levels of AMP
gene expression than did wild-type ﬂies, demonstrating that
the eiger phenotype is not caused by reduction in Toll or imd
signaling.
As Toll and imd signaling, and thus the majority of the
antimicrobial peptide response in the ﬂy [15], does not seem
to be responsible for changes in eiger mutants, we next probed
the cellular immune response (Figure 4). To determine
whether eiger mutations might affect hemocyte function, we
monitored phagocytosis in eiger mutants. Fluorescein iso-
thiocyanate (FITC)-labeled S. aureus were injected into the
hemocoel of wild-type or eiger mutant ﬂies and the injected
ﬂies were given 1 h to phagocytose the particles. S. aureus was
chosen because FITC-labeled dead S. aureus are commercially
available and we predicted that eiger alters the ability of
hemocytes to ﬁght this pathogen. Trypan blue was injected
into the hemocoel of the ﬂies following the 1-h incubation
period. This dye quenches the ﬂuorescence of extracellular
FITC but allows phagocytosed particles to ﬂuoresce brightly
[16]. The ﬂies were examined around the dorsal anterior
abdomen because hemocytes tend to gather in this area.
Changes in phagocytosis can be seen by changes in the
numbers of phagocytosing cells or by the ﬂuorescence
intensity. Both of these characteristics appear altered in eiger
mutants compared to parental ﬂies, suggesting that eiger
mutant hemocytes were either reduced in number or had
reduced phagocytic activity, or both.
We note that uninfected eiger mutants live longer than wild-
type ﬂies. This raises the possibility that the increased survival
of eiger mutant ﬂies after infection with M. marinum or
S. typhimurium is simply a consequence of general increased
longevity. We argue that this possibility is unlikely, because it
assumes that the cause of death due to old age is the same as
the cause of death by infection; this is not observed in other
animals and it is not supported by examination of published
microarray studies of ﬂies dying from infection or old age
[12,17,18]. Instead, we argue that eiger is a driver of patho-
genesis. If eiger is indeed required to ﬁght infections but can
also cause pathology, then the phenotype we observed for a
given infection is likely the sum of the positive and negative
effects of eiger. Regardless of the interpretation of the effects
of eiger on S. typhimurium and M. marinum, the important result
remains that eiger mutations divide the ﬂy’s response to
pathogens into two groups.
Why does eiger affect different microbes in different ways?
We argue that E. coli is removed from ﬂies so rapidly and via
so many mechanisms that the effects of eiger cannot be
measured easily because of redundancy. In contrast, during
an infection with a real pathogen, it may be easier to measure
changes in immunity because the ﬂy is ﬁghting hard for
survival and its immune mechanisms are not acting in a
redundant fashion. Extracellular pathogens are clearly fought
by the ﬂy using eiger-dependent mechanisms because the loss
of eiger results in a deeply sensitive phenotype. It is intriguing
that ﬂies lacking eiger are no worse at ﬁghting intracellular
pathogens. This suggests that these intracellular pathogens
are normally immune to the effects of wild-type eiger.
Intracellular pathogens like M. marinum, L. monocytogenes, and
S. typhimurium use different virulence mechanisms for grow-
ing inside cells, but the common thread is that they can
survive in professional phagocytes. We suggest that eiger
function somehow alters hemocytes to increase their potency
against microbes. The reduced ability of eiger mutant
hemocytes to phagocytose S. aureus compared to wild-type
hemocytes supports this hypothesis. We predict that this
change in potency is effective against pathogens that grow
extracellularly but not against pathogens that have already
developed methods of defeating phagocytes.
We propose that where eiger signaling does not help ﬁght
infection, eiger can cause pathology. This eiger-induced
pathology may be linked to the immune function of eiger—
for example, the induced immune response may be energeti-
cally wasteful or directly toxic. Alternatively, eiger-induced
pathology may be separable from the immune function—for
example, eiger could cause something like muscle wasting in
Figure 3. Antimicrobial Gene Expression Differences between eiger
Mutants and Wild-Type Controls
Flies were injected with an LB control, B. cepacia, S. typhimurium, L.
monocytogenes, or S. aureus or left uninjected. RNA was harvested after a
6-h incubation at 29 8C, and quantitative RT-PCR was used to assay
drosomycin (A) and diptericin (B) gene expression levels relative to a
ribosomal protein 15a control. White bars indicate the w
1118 parental
control; grey bars, w
1118; egr
1/egr
3 One asterisk indicates p , 0.01; two
asterisks, p , 0.001 using Tukey’s multiple-comparison test following
one-way ANOVA. Unmarked parental/mutant pairs do not differ in a
statistically significant manner. No differences were seen with drosmycin
expression between mutant and parental lines, whereas eiger mutant
flies transcribed 2- to 3-fold more diptericin (during a 150- to 1,100-fold
induction compared with uninjected flies) than did their parents, when
challenged with LB, B. cepacia, or S. typhimurium.
doi:10.1371/journal.ppat.0030041.g003
Figure 4. Phagocytosis in eiger Mutants
Week-old male flies were injected with FITC-labeled dead S. aureus and
allowed to phagocytose the particles and then were injected with Trypan
blue to quench extracellular fluorescence. The dorsal abdomen of the fly
was photographed under epifluoresence optics. Anterior is on the left.
(A) Wild-type fly (w
1118); (B) eiger mutant fly (w
1118; egr
1/egr
3). Bright spots
indicate hemocytes that have phagocytosed the S. aureus. The pictures
are representative of the 15 flies examined for the experiment.
doi:10.1371/journal.ppat.0030041.g004
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vertebrates [19].
Genetic screens that monitored AMP synthesis have been
productive and ﬁlled in the Toll and imd pathways but did not
reveal eiger signaling [20,21]. As we have shown, the role eiger
plays in innate immunity cannot be measured using a
nonpathogenic microbe like E. coli. This study demonstrates
that there are important immune mechanisms at work in the
ﬂy that are difﬁcult to see using simple endpoints like
antimicrobial gene expression; however, studies with mi-
crobes that can cause disease in wild-type ﬂies—real
pathogens—can reveal these physiologies.
Materials and Methods
Fly strains. The wild-type parental strain used in all experiments is
white
1118. The eiger alleles white
1118;egr
1 and white
1118;egr
3 were kept as
homozygous stocks and crossed to make heterozygous ﬂies as
required [22]. We used this heterozygous combination to reduce the
probability that there were other mutations on the chromosome that
affected pathogenesis. To control for variation in the ﬂies, we
infected only 5- to 7-d-old male ﬂies.
Bacterial strains. Strains used are listed in Table 1.
Pathogen culture conditions. B. bassiana cultures were grown on
malt agar at 29 8C for 2 wk or until a sufﬁcient density was reached,
and the cultures were allowed to sporulate. Anesthetized ﬂies were
shaken on the plates for 30 s to coat ﬂies with spores. Flies were
transferred to fresh vials and incubated at 29 8C for the duration of
the survival experiment.
S. pneumoniae cultures were grown standing at 37 8C5 %C O 2 in
brain heart infusion medium (BHI) to an OD600 of 0.15, and aliquots
were frozen at 80 8C in 10% glycerol. For infection, an aliquot of
S. pneumoniae was thawed, diluted 1:3 in fresh BHI, and allowed to
adjust at 37 8C5 %C O 2 for 1.5 h. E. coli, S. typhimurium, E. faecalis, and
S. aureus cultures were grown overnight in Luria Bertani (LB) medium
at 37 8C. L. monocytogenes was grown standing overnight in BHI
medium.
B. cepacia, L. monocytogenes, S. pneumoniae, and S. typhimurium were grown
standing, while E. coli, E. faecalis, and S. aureus were shaken. M. marinum
was cultured standing at 29 8C in Middlebrook 7H9 broth
supplemented with Middlebrook oleic acid–albumin–dextrose–cata-
lase enrichment and 0.2% Tween. Then 50 nl of bacteria was injected
at the following optical densities (OD600): B. cepacia, 0.0001–0.001;
E. coli, 0.1; E. faecalis, 0.5; L. monocytogenes, 0.01; M. marinum, 0.05;
S. aureus, 0.001; S. pneumoniae, 0.05; and S. typhimurium, 0.1.
Injection. Five- to 7-d posteclosion male ﬂies were used for
injection. The ﬂies were raised at 25 8C, 65% humidity, on yeasted
dextrose food. Flies were anesthetized with CO2. Injections were
carried out with a pulled glass capillary needle. A picospritzer (Parker
Hanniﬁn, http://www.parker.com) was used to inject 50 nl of liquid
into each ﬂy with needles that were individually calibrated by
measuring the size of the expelled drop under oil. Reproducibility
was measured by determining the number of bacteria injected at time
zero and can be seen in Figure 2. Injected ﬂies were incubated 20 ﬂies
to a vial and placed at 29 8C, 65% humidity with the exception of
B. cepacia and M. marinum. B. cepacia infections were performed at 18
8C in the dark, and humidity was not controlled in this experiment.
This temperature was used because B. cepacia is so pathogenic that it is
difﬁcult to obtain sufﬁcient survival at higher temperatures to
observe changes in death rates. M. marinum infections were carried
out at 25 8C, 65% humidity, in the dark.
Survival curves. Parental ﬂies (w
1118) and w
1118; eiger
1/eiger
3 mutants
were injected with the microbe of choice or medium as a control.
Sixty ﬂies were assayed for each survival curve, and they were placed
in three vials of 20 ﬂies each. Death was recorded daily. Data were not
censored. Survival curves are plotted as Kaplan-Meier plots, and
statistical signiﬁcance is tested using log-rank analysis using Prism
software (http://www.prism-software.com). Kaplan-Meier plots are
shown in Figure 1, and survival curves showing the variance in the
data are included in Figure S1. All experiments were performed at
least three times and yielded similar results.
CFU determination. Following challenge with microbes, six
individual ﬂies were collected at each time point. These ﬂies were
homogenized, diluted serially, and plated onto appropriate media
(blood agar for S. pneumoniae, LB for all others). E. faecalis CFUs were
determined by testing three groups of six ﬂies for each time point.
The data are plotted as boxes with whiskers. The median is indicated
with a bold line. The boxes indicate the extent of the third and ﬁrst
quartiles, while the whiskers show the complete range of the data.
Statistical signiﬁcance was determined using nonparametric two-
tailed t-tests. All experiments were performed at least three times and
yielded similar results.
Antimicrobial peptide gene expression. Flies were injected with 50
nl of the indicated microbes or controls. Following injection, the ﬂies
were placed in vials containing yeasted dextrose food and incubated
at 29 8C for 6 h. Groups of ﬁve ﬂies were homogenized in TriZOL and
stored at 70 8C until processed. RNA was isolated using a standard
TriZOL preparation, and the samples were treated with DNase
(Promega, http://www.promega.com). Quantitative RT-PCR was per-
formed as described [23] previously using a Bio-Rad icycler (http://
www.bio-rad.com) and the following primer sets: drosomycin 59-
gracttgttcgccctcttcg, drosomycin 39-cttgcacacacgacgacag, drosomycin
Taqman probe tccggaagatacaagggtccctgtg, diptericin 59-accgcagtacc-
cactcaatc, diptericin 39-cccaagtgctgtccatatcc, and diptericin Taqman
probe cagtccagggtcaccagaaggtgtg. The data shown in Figure 4 include
six biological replicates of each treatment condition, and each data
point was calculated as the mean of two technical replicates. This
experiment was repeated once using a set of three biological
replicates with similar results. The data are plotted as boxes with
whiskers. The median is indicated with a bold line. The boxes indicate
the extent of the third and ﬁrst quartiles, while the whiskers show the
complete range of the data.
Phagocytosis assays. Flies were injected with 50 nl of 1 mg/ml
FITC-labeled S. aureus (Molecular Probes, http://probes.invitrogen.
com) in water. The ﬂies were allowed to phagocytose the particles for
1 h and then were injected in the thorax with approximately 250 llo f
4% Trypan blue: this quenches the ﬂuorescence of extracellular
bacteria but permits the phagocytosed particles to ﬂuoresce. The
wings of the ﬂies were removed with iris scissors, and the ﬂies were
pinned with a minuten pin and photographed using epiﬂuorescent
illumination with a Leica MZ3 microscope ﬁtted with an ORCA
camera. Images were captured with Openlab (Improvision) software
(http://www.improvision.com). The exposure was set such that the
brightest images had a small number of saturating pixels. The
experiment was repeated three times with at least ﬁve ﬂies for each
treatment.
Supporting Information
Figure S1. Variance in Survival of eiger-Infected Flies
Week-old male ﬂies were infected with pathogens and survival was
monitored daily. (A) S. typhimurium; (B) M. marinum, (C) L. mono-
cytogenes, (D) E. coli, (E) S. aureus, (F) E. faecalis, (G) B. bassiana, (H)
S. pneumoniae, and (I) B. cepacia. Circles indicate medium-injected eiger;
diamonds, microbe-injected eiger; squares, microbe-injected parental;
triangles, medium-injected parental. The mean is plotted, and error
bars show the standard deviation from three groups of 20 injected
ﬂies.
Found at doi:10.1371/journal.ppat.0030041.sg001 (1.4 MB AI).
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